Jing Chen1, Jonas Bacelis2,3, Pol Sole-Navais2, Amit Srivastava4,5, Julius Juodakis2, Amy Rouse5, Mikko Hallman6, Kari Teramo7, Mads Melbye8,9,10, Bjarke Feenstra8, Rachel M Freathy11, George Davey Smith12,13,14, Deborah A Lawlor12,13,14, Jeffrey C Murray15, Scott M Williams16, Bo Jacobsson2,17, Louis J Muglia4,5, Ge Zhang4,5. 1. Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America. 2. Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. 3. Region Västra Götaland, Sahlgrenska University Hospital, Department of Obstetrics and Gynecology, Gothenburg, Sweden. 4. Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America. 5. Center for Prevention of Preterm Birth, Perinatal Institute and March of Dimes Prematurity Research Center Ohio Collaborative, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America. 6. PEDEGO Research Unit and Medical Research Center Oulu, University of Oulu and Department of Children and Adolescents, Oulu University Hospital, Oulu, Finland. 7. Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. 8. Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark. 9. Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. 10. Department of Medicine, Stanford University School of Medicine, Stanford, California, United States of America. 11. Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, United Kingdom. 12. MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, United Kingdom. 13. Population Health Science, Bristol Medical School, University of Bristol, Bristol, United Kingdom. 14. Bristol NIHR Biomedical Research Centre, United Kingdom. 15. Department of Pediatrics, University of Iowa, Iowa City, Iowa, United States of America. 16. Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America. 17. Department of Genetics and Bioinformatics, Domain of Health Data and Digitalisation, Institute of Public Health, Oslo, Norway.
Abstract
BACKGROUND: Many maternal traits are associated with a neonate's gestational duration, birth weight, and birth length. These birth outcomes are subsequently associated with late-onset health conditions. The causal mechanisms and the relative contributions of maternal and fetal genetic effects behind these observed associations are unresolved. METHODS AND FINDINGS: Based on 10,734 mother-infant duos of European ancestry from the UK, Northern Europe, Australia, and North America, we constructed haplotype genetic scores using single-nucleotide polymorphisms (SNPs) known to be associated with adult height, body mass index (BMI), blood pressure (BP), fasting plasma glucose (FPG), and type 2 diabetes (T2D). Using these scores as genetic instruments, we estimated the maternal and fetal genetic effects underlying the observed associations between maternal phenotypes and pregnancy outcomes. We also used infant-specific birth weight genetic scores as instrument and examined the effects of fetal growth on pregnancy outcomes, maternal BP, and glucose levels during pregnancy. The maternal nontransmitted haplotype score for height was significantly associated with gestational duration (p = 2.2 × 10-4). Both maternal and paternal transmitted height haplotype scores were highly significantly associated with birth weight and length (p < 1 × 10-17). The maternal transmitted BMI scores were associated with birth weight with a significant maternal effect (p = 1.6 × 10-4). Both maternal and paternal transmitted BP scores were negatively associated with birth weight with a significant fetal effect (p = 9.4 × 10-3), whereas BP alleles were significantly associated with gestational duration and preterm birth through maternal effects (p = 3.3 × 10-2 and p = 4.5 × 10-3, respectively). The nontransmitted haplotype score for FPG was strongly associated with birth weight (p = 4.7 × 10-6); however, the glucose-increasing alleles in the fetus were associated with reduced birth weight through a fetal effect (p = 2.2 × 10-3). The haplotype scores for T2D were associated with birth weight in a similar way but with a weaker maternal effect (p = 6.4 × 10-3) and a stronger fetal effect (p = 1.3 × 10-5). The paternal transmitted birth weight score was significantly associated with reduced gestational duration (p = 1.8 × 10-4) and increased maternal systolic BP during pregnancy (p = 2.2 × 10-2). The major limitations of the study include missing and heterogenous phenotype data in some data sets and different instrumental strength of genetic scores for different phenotypic traits. CONCLUSIONS: We found that both maternal height and fetal growth are important factors in shaping the duration of gestation: genetically elevated maternal height is associated with longer gestational duration, whereas alleles that increase fetal growth are associated with shorter gestational duration. Fetal growth is influenced by both maternal and fetal effects and can reciprocally influence maternal phenotypes: taller maternal stature, higher maternal BMI, and higher maternal blood glucose are associated with larger birth size through maternal effects; in the fetus, the height- and metabolic-risk-increasing alleles are associated with increased and decreased birth size, respectively; alleles raising birth weight in the fetus are associated with shorter gestational duration and higher maternal BP. These maternal and fetal genetic effects may explain the observed associations between the studied maternal phenotypes and birth outcomes, as well as the life-course associations between these birth outcomes and adult phenotypes.
BACKGROUND: Many maternal traits are associated with a neonate's gestational duration, birth weight, and birth length. These birth outcomes are subsequently associated with late-onset health conditions. The causal mechanisms and the relative contributions of maternal and fetal genetic effects behind these observed associations are unresolved. METHODS AND FINDINGS: Based on 10,734 mother-infant duos of European ancestry from the UK, Northern Europe, Australia, and North America, we constructed haplotype genetic scores using single-nucleotide polymorphisms (SNPs) known to be associated with adult height, body mass index (BMI), blood pressure (BP), fasting plasma glucose (FPG), and type 2 diabetes (T2D). Using these scores as genetic instruments, we estimated the maternal and fetal genetic effects underlying the observed associations between maternal phenotypes and pregnancy outcomes. We also used infant-specific birth weight genetic scores as instrument and examined the effects of fetal growth on pregnancy outcomes, maternal BP, and glucose levels during pregnancy. The maternal nontransmitted haplotype score for height was significantly associated with gestational duration (p = 2.2 × 10-4). Both maternal and paternal transmitted height haplotype scores were highly significantly associated with birth weight and length (p < 1 × 10-17). The maternal transmitted BMI scores were associated with birth weight with a significant maternal effect (p = 1.6 × 10-4). Both maternal and paternal transmitted BP scores were negatively associated with birth weight with a significant fetal effect (p = 9.4 × 10-3), whereas BP alleles were significantly associated with gestational duration and preterm birth through maternal effects (p = 3.3 × 10-2 and p = 4.5 × 10-3, respectively). The nontransmitted haplotype score for FPG was strongly associated with birth weight (p = 4.7 × 10-6); however, the glucose-increasing alleles in the fetus were associated with reduced birth weight through a fetal effect (p = 2.2 × 10-3). The haplotype scores for T2D were associated with birth weight in a similar way but with a weaker maternal effect (p = 6.4 × 10-3) and a stronger fetal effect (p = 1.3 × 10-5). The paternal transmitted birth weight score was significantly associated with reduced gestational duration (p = 1.8 × 10-4) and increased maternal systolic BP during pregnancy (p = 2.2 × 10-2). The major limitations of the study include missing and heterogenous phenotype data in some data sets and different instrumental strength of genetic scores for different phenotypic traits. CONCLUSIONS: We found that both maternal height and fetal growth are important factors in shaping the duration of gestation: genetically elevated maternal height is associated with longer gestational duration, whereas alleles that increase fetal growth are associated with shorter gestational duration. Fetal growth is influenced by both maternal and fetal effects and can reciprocally influence maternal phenotypes: taller maternal stature, higher maternal BMI, and higher maternal blood glucose are associated with larger birth size through maternal effects; in the fetus, the height- and metabolic-risk-increasing alleles are associated with increased and decreased birth size, respectively; alleles raising birth weight in the fetus are associated with shorter gestational duration and higher maternal BP. These maternal and fetal genetic effects may explain the observed associations between the studied maternal phenotypes and birth outcomes, as well as the life-course associations between these birth outcomes and adult phenotypes.
Authors: Peter H Whincup; Samantha J Kaye; Christopher G Owen; Rachel Huxley; Derek G Cook; Sonoko Anazawa; Elizabeth Barrett-Connor; Santosh K Bhargava; Bryndís E Birgisdottir; Sofia Carlsson; Susanne R de Rooij; Roland F Dyck; Johan G Eriksson; Bonita Falkner; Caroline Fall; Tom Forsén; Valdemar Grill; Vilmundur Gudnason; Sonia Hulman; Elina Hyppönen; Mona Jeffreys; Debbie A Lawlor; David A Leon; Junichi Minami; Gita Mishra; Clive Osmond; Chris Power; Janet W Rich-Edwards; Tessa J Roseboom; Harshpal Singh Sachdev; Holly Syddall; Inga Thorsdottir; Mauno Vanhala; Michael Wadsworth; Donald E Yarbrough Journal: JAMA Date: 2008-12-24 Impact factor: 56.272
Authors: Boyd E Metzger; Lynn P Lowe; Alan R Dyer; Elisabeth R Trimble; Udom Chaovarindr; Donald R Coustan; David R Hadden; David R McCance; Moshe Hod; Harold David McIntyre; Jeremy J N Oats; Bengt Persson; Michael S Rogers; David A Sacks Journal: N Engl J Med Date: 2008-05-08 Impact factor: 91.245
Authors: Debbie A Lawlor; Roger M Harbord; Jonathan A C Sterne; Nic Timpson; George Davey Smith Journal: Stat Med Date: 2008-04-15 Impact factor: 2.373
Authors: O Yaw Addo; Aryeh D Stein; Caroline H Fall; Denise P Gigante; Aravinda M Guntupalli; Bernardo L Horta; Christopher W Kuzawa; Nanette Lee; Shane A Norris; Poornima Prabhakaran; Linda M Richter; Harshpal S Sachdev; Reynaldo Martorell Journal: J Pediatr Date: 2013-03-07 Impact factor: 4.406
Authors: Ge Zhang; Bo Jacobsson; Jonas Bacelis; Julius Juodakis; Kristina M Adams Waldorf; Verena Sengpiel; Louis J Muglia Journal: BMJ Open Date: 2018-10-31 Impact factor: 2.692
Authors: Thorhildur Juliusdottir; Valgerdur Steinthorsdottir; Lilja Stefansdottir; Gardar Sveinbjornsson; Erna V Ivarsdottir; Rosa B Thorolfsdottir; Jon K Sigurdsson; Vinicius Tragante; Kristjan E Hjorleifsson; Anna Helgadottir; Michael L Frigge; Gudmundur Thorgeirsson; Rafn Benediktsson; Emil L Sigurdsson; David O Arnar; Thora Steingrimsdottir; Ingileif Jonsdottir; Hilma Holm; Daniel F Gudbjartsson; Gudmar Thorleifsson; Unnur Thorsteinsdottir; Kari Stefansson Journal: Nat Genet Date: 2021-07-19 Impact factor: 38.330
Authors: Deborah A Lawlor; Marjo-Riitta Järvelin; Tom A Bond; Rebecca C Richmond; Ville Karhunen; Gabriel Cuellar-Partida; Maria Carolina Borges; Verena Zuber; Alexessander Couto Alves; Dan Mason; Tiffany C Yang; Marc J Gunter; Abbas Dehghan; Ioanna Tzoulaki; Sylvain Sebert; David M Evans; Alex M Lewin; Paul F O'Reilly Journal: BMC Med Date: 2022-02-01 Impact factor: 11.150